« Devastating Cost of Failure to Coordinate Economic Re-openings; Immediate need for a Coordinated Policy across States, Regions, and Nations around the world — says MIT Study. | Main | Renault DP World F1 Team makes a dramatic finish in 2020 Formula 1 Pirelli British Grand Prix, Sunday. »
August 3, 2020
Drugs Controller General of India approves Phase II+III trials of Oxford University vaccine by Serum Institute, Pune.
New Delhi, August 03, 2020. — The Drugs Controller General of India (DCGI) has allowed the Serum Institute of India, Pune, to conduct Phase II+III clinical trials of the Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD). This approval will hasten the development of the COVID-19 vaccine in India, India’s Ministry of Health and Family Welfare announced today.
Source: Ministry of Health and Family Welfare, Government of India.
|GlobalGiants.Com|
— The editor is a holder of an Oxford Alumni Card and is a member of the Oxford and Cambridge Society of India.
![del.icio.us del.icio.us](https://globalgiants.com/images/bookmarks/delicious.png)
![StumbleUpon StumbleUpon](https://globalgiants.com/images/bookmarks/stumbleupon.png)
![reddit reddit](https://globalgiants.com/images/bookmarks/reddit.png)
![Facebook Facebook](https://globalgiants.com/images/bookmarks/facebook.png)
![Google Plus Google Plus](https://globalgiants.com/images/bookmarks/googleplus.png)
![Tweet This Tweet This](https://globalgiants.com/images/bookmarks/twitter.png)
![Seed This on Newsvine Seed This on Newsvine](https://globalgiants.com/images/bookmarks/newsvine.png)
Edited & Posted by the Editor | 6:20 AM | Link to this Post